Thyroid Disorders in Preterm Infants: Prevalence, Etiologies, and Thyroid Function Test Characteristics
24
item.page.dc.date.issued
2026-09-01
item.page.dc.type
item.page.dc.identifier.eissn
22288082
item.page.dc.identifier.doi
item.page.dc.identifier.scopus
2-s2.0-105049648268
item.page.oaire.citation.title
Siriraj Medical Journal
item.page.oaire.citation.volume
78
item.page.oaire.citation.issue
9
item.page.oaire.citation.startPage
649
item.page.oaire.citation.endPage
659
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Siriraj Medical Journal Vol.78 No.9 (2026) , 649-659
punsarn.item.page.citation
Vathanasakpuban P., Yangthara B., Vatanavicharn N., Liammongkolkul S., Lertbannaphong O. Thyroid Disorders in Preterm Infants: Prevalence, Etiologies, and Thyroid Function Test Characteristics. Siriraj Medical Journal Vol.78 No.9 (2026) , 649-659. 659. doi:10.33192/smj.v78i9.281716 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/118867
item.page.dc.title
Thyroid Disorders in Preterm Infants: Prevalence, Etiologies, and Thyroid Function Test Characteristics
item.page.dc.contributor.author
item.page.oairecerif.author.affiliation
item.page.dc.contributor.correspondence
item.page.dc.contributor.other
item.page.dc.description.abstract
Objective: To determine the prevalence, etiologies, risk factors, and characteristics of thyroid disorders in preterm infants. Materials and Methods: This retrospective review included eligible infants with gestational age (GA) < 37 weeks born at Siriraj Hospital in 2022. Infants with genetic syndromes, chromosomal abnormalities, or maternal thyroid disease were excluded. Thyroid-stimulating hormone (TSH) from neonatal dried blood spots was measured using time-resolved fluoroimmunoassay at 48–72 hours and again at 2 weeks of age (cutoff ≥ 12 mIU/L), followed by serum thyroid function tests (electrochemiluminescence immunoassay) obtained at 4 weeks until term-corrected age (cutoff ≥ 12.53 mIU/L). Risk factors were identified using multiple logistic regression. Results: Among 603 preterm infants, the mean gestational age was 35 weeks and the mean birth weight was 2,230 g. Thyroid disorder prevalence was 2.99% (18/603), with hyperthyrotropinemia being the most common diagnosis. Multiple variables were analyzed but only the 5-minute Apgar score (P = 0.013; adjusted odds ratio 0.635; 95% CI 0.443–0.910) and maternal preeclampsia (P = 0.039; adjusted odds ratio 5.064; 95% CI 1.084–23.661) were associated with hyperthyrotropinemia. TSH levels increased from the first to second week of life in infants with GA 28–33 weeks, but decreased in those with GA 34–36 weeks. Free thyroxine increased with GA in infants < 34 weeks but decreased in GA 34–36 weeks. Conclusions: The prevalence of thyroid disorders was approximately 3%, with hyperthyrotropinemia being the most common. Lower 5-minute Apgar scores and maternal preeclampsia were associated with hyperthyrotropinemia. TSH and free thyroxine levels tended to increase in infants with GA < 34 weeks but decrease in those with GA > 34 weeks. Abnormal TFTs were detected in subsequent weeks of life, supporting the practice of repeated TSH screening in preterm infants until term. More large-scale, prospective studies are needed to follow preterm infants with thyroid disorders to assess cognitive, motor, and behavioral outcomes.
